Melanoma is one of the commonest cancers in Queensland and imposes a huge toll on both the community and health system.
Melanomas of the skin are distinguished by their propensity for metastatic spread via lymphatic vessels to regional lymph nodes, even at early stages of invasion. Currently there are few data on determinants of melanoma progression or quality of life of the affected patients. New prognostic knowledge is needed to refine the strategies that enable clinicians to identify the patient population with primary melanoma who are at risk of developing spread of their disease.
This prospective study of approximately 800 melanoma patients diagnosed in Queensland between 2010 and 2014 aims to assess the potential roles of epidemiologic factors and quality of life in the progression of Stage Ib and stage II primary cutaneous melanoma.